|

Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome

RECRUITINGSponsored by University Hospital, Bonn
Actively Recruiting
SponsorUniversity Hospital, Bonn
Started2018-01-01
Est. completion2025-07-31
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03584204

Summary

The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* liver cirrhosis of any etiology
* CT scan available

Exclusion Criteria:

* HCC or any malignant disease

Conditions2

Liver CirrhosisLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.